{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:19:34Z","timestamp":1745554774142,"version":"3.40.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["oooojournal.net","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.oooo.2024.12.009","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T18:36:08Z","timestamp":1735065368000},"page":"660-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the efficacy of surgical and non-surgical treatment modalities in the management of medication-related osteonecrosis of the jaw: a retrospective study"],"prefix":"10.1016","volume":"139","author":[{"given":"Eugene Chung Hon","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin Chee Wee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian Hongyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo Nian","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella Jinran","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Ehsan","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul Harshad","family":"Nagadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.oooo.2024.12.009_bib0001","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaw\u20132022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofacial Surg"},{"issue":"9","key":"10.1016\/j.oooo.2024.12.009_bib0002","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"10.1016\/j.oooo.2024.12.009_bib0003","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","article-title":"Oral health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.oooo.2024.12.009_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Min Res"},{"issue":"1","key":"10.1016\/j.oooo.2024.12.009_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int J Implant Dent"},{"issue":"4","key":"10.1016\/j.oooo.2024.12.009_bib0006","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COC.0b013e3182155fcb","article-title":"A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates","volume":"35","author":"Thumbigere-Math","year":"2012","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.oooo.2024.12.009_bib0007","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.oooo.2024.12.009_bib0008","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.joms.2021.12.007","article-title":"Prevalence, incidence rate, and risk factors of medication-related osteonecrosis of the jaw in patients with osteoporosis and cancer: a nationwide population-based study in Japan","volume":"80","author":"Ishimaru","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.oooo.2024.12.009_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113505","article-title":"Management of medication-related osteonecrosis of the jaw (MRONJ) using leukocyte- and platelet-rich fibrin (L-PRF) and photobiomodulation: a retrospective Study","volume":"9","author":"Tenore","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.oooo.2024.12.009_bib0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: a systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Diseases"},{"issue":"11","key":"10.1016\/j.oooo.2024.12.009_bib0011","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"J Am Dental Associat"},{"issue":"2","key":"10.1016\/j.oooo.2024.12.009_bib0012","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00520-020-05556-0","article-title":"Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review","volume":"29","author":"Ng","year":"2021","journal-title":"Support Care Cancer"},{"issue":"31","key":"10.1016\/j.oooo.2024.12.009_bib0013","first-page":"1","article-title":"Medication-related osteonecrosis of the jaw: a narrative review of risk factors, diagnosis, and management","volume":"5","author":"Thomas","year":"2023","journal-title":"Front Oral Maxillofac Med"},{"issue":"10","key":"10.1016\/j.oooo.2024.12.009_bib0014","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.oooo.2024.12.009_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tripleo.2010.02.020","article-title":"Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study","volume":"110","author":"Scoletta","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"10.1016\/j.oooo.2024.12.009_bib0016","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jcms.2018.12.014","article-title":"Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study","volume":"47","author":"Ristow","year":"2019","journal-title":"J Cranio-Maxillofacial Surg"},{"issue":"6","key":"10.1016\/j.oooo.2024.12.009_bib0017","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2257.2006.00841.x","article-title":"Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma","volume":"28","author":"Elad","year":"2006","journal-title":"Clinical & Laboratory Haematology"},{"issue":"4","key":"10.1016\/j.oooo.2024.12.009_bib0018","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.joms.2013.12.007","article-title":"Management of antiresorptive osteonecrosis of the jaws with primary surgical resection","volume":"72","author":"Carlson","year":"2014","journal-title":"J Oral Maxillofacial Surg"},{"issue":"1-2","key":"10.1016\/j.oooo.2024.12.009_bib0019","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/odi.12764","article-title":"Medication-related osteonecrosis of the jaw: surgical or non-surgical treatment?","volume":"24","author":"Favia","year":"2018","journal-title":"Oral Dis"},{"issue":"12","key":"10.1016\/j.oooo.2024.12.009_bib0020","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","article-title":"Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw","volume":"73","author":"Ruggiero","year":"2015","journal-title":"J Oral Maxillofacial Surg"},{"issue":"5","key":"10.1016\/j.oooo.2024.12.009_bib0021","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00432-010-0953-1","article-title":"Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"137","author":"M\u00fccke","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.oooo.2024.12.009_bib0022","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcms.2020.02.017","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) stage III: conservative and conservative surgical approaches versus an aggressive surgical intervention: a systematic review","volume":"48","author":"Vanpoecke","year":"2020","journal-title":"J Cranio-Maxillofacial Surg"},{"issue":"5","key":"10.1016\/j.oooo.2024.12.009_bib0023","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofacial Surg"},{"issue":"11","key":"10.1016\/j.oooo.2024.12.009_bib0024","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.joms.2018.05.025","article-title":"Nonsurgical management of medication-related osteonecrosis of the jaws using local wound care","volume":"76","author":"Hadaya","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.oooo.2024.12.009_bib0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"10.1016\/j.oooo.2024.12.009_bib0026","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joms.2013.06.188","article-title":"Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis","volume":"72","author":"Magremanne","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.oooo.2024.12.009_bib0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.oooo.2016.06.019","article-title":"Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series","volume":"122","author":"Owosho","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"26","key":"10.1016\/j.oooo.2024.12.009_bib0028","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.19.02192","article-title":"Teriparatide promotes bone healing in medication-related osteonecrosis of the jaw: a placebo-controlled, randomized trial","volume":"38","author":"Sim","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.oooo.2024.12.009_bib0029","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.oooo.2020.10.018","article-title":"Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study","volume":"131","author":"Otto","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"7","key":"10.1016\/j.oooo.2024.12.009_bib0030","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.oooo.2024.12.009_bib0031","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.oooo.2018.06.007","article-title":"Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study","volume":"126","author":"Giudice","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"10.1016\/j.oooo.2024.12.009_bib0032","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"J Cranio-Maxillofacial Surg"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440324009386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440324009386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:27:39Z","timestamp":1745497659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440324009386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2212440324009386"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2024.12.009","relation":{},"ISSN":["2212-4403"],"issn-type":[{"type":"print","value":"2212-4403"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the efficacy of surgical and non-surgical treatment modalities in the management of medication-related osteonecrosis of the jaw: a retrospective study","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}